| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Iran | 153 | 2024 | 762 | 15.970 |
Why?
|
| Quality-Adjusted Life Years | 61 | 2024 | 1740 | 4.940 |
Why?
|
| Accidents, Traffic | 8 | 2023 | 818 | 3.580 |
Why?
|
| Sodium Chloride, Dietary | 6 | 2021 | 300 | 3.220 |
Why?
|
| Automobile Driving | 6 | 2023 | 442 | 3.110 |
Why?
|
| Cost of Illness | 21 | 2023 | 1949 | 2.670 |
Why?
|
| Prevalence | 72 | 2024 | 15835 | 2.570 |
Why?
|
| Disabled Persons | 10 | 2024 | 1209 | 2.320 |
Why?
|
| Child Mortality | 7 | 2023 | 204 | 2.270 |
Why?
|
| Life Expectancy | 15 | 2024 | 1248 | 2.240 |
Why?
|
| Hypertension | 21 | 2024 | 8616 | 2.090 |
Why?
|
| Incidence | 53 | 2024 | 21527 | 1.960 |
Why?
|
| Diabetes Mellitus | 23 | 2024 | 5888 | 1.950 |
Why?
|
| Overweight | 9 | 2024 | 2447 | 1.850 |
Why?
|
| Quality of Health Care | 20 | 2024 | 4306 | 1.790 |
Why?
|
| Health Surveys | 18 | 2022 | 4055 | 1.770 |
Why?
|
| Tobacco Smoke Pollution | 4 | 2023 | 828 | 1.630 |
Why?
|
| Infant Mortality | 5 | 2023 | 751 | 1.580 |
Why?
|
| Wounds and Injuries | 13 | 2021 | 2513 | 1.490 |
Why?
|
| Hypercholesterolemia | 7 | 2023 | 1145 | 1.470 |
Why?
|
| Middle East | 14 | 2024 | 234 | 1.450 |
Why?
|
| Male | 170 | 2024 | 364154 | 1.420 |
Why?
|
| Risk Factors | 78 | 2024 | 74889 | 1.400 |
Why?
|
| Age Distribution | 23 | 2024 | 2869 | 1.350 |
Why?
|
| Humans | 267 | 2024 | 766812 | 1.350 |
Why?
|
| Endocarditis | 3 | 2024 | 352 | 1.340 |
Why?
|
| Myocardial Ischemia | 5 | 2024 | 2131 | 1.320 |
Why?
|
| Sex Distribution | 20 | 2024 | 2274 | 1.300 |
Why?
|
| Female | 171 | 2024 | 396532 | 1.300 |
Why?
|
| Africa, Northern | 10 | 2024 | 86 | 1.290 |
Why?
|
| Epidemiologic Research Design | 15 | 2014 | 368 | 1.280 |
Why?
|
| Dental Caries | 2 | 2023 | 429 | 1.270 |
Why?
|
| Obesity | 16 | 2024 | 13090 | 1.210 |
Why?
|
| Cardiovascular Diseases | 26 | 2024 | 15652 | 1.170 |
Why?
|
| Stomach Neoplasms | 7 | 2023 | 1480 | 1.160 |
Why?
|
| Developing Countries | 21 | 2024 | 2912 | 1.140 |
Why?
|
| Pyrenes | 2 | 2024 | 51 | 1.110 |
Why?
|
| Prediabetic State | 2 | 2023 | 547 | 1.110 |
Why?
|
| Feeding Behavior | 7 | 2023 | 3208 | 1.090 |
Why?
|
| Hepatitis C | 3 | 2022 | 1595 | 1.080 |
Why?
|
| Particulate Matter | 7 | 2024 | 2621 | 1.080 |
Why?
|
| Air Pollution, Indoor | 2 | 2024 | 931 | 1.060 |
Why?
|
| Cross-Sectional Studies | 42 | 2024 | 26309 | 1.050 |
Why?
|
| Adult | 113 | 2024 | 223305 | 1.050 |
Why?
|
| Air Pollutants | 5 | 2024 | 2919 | 1.030 |
Why?
|
| Mortality | 16 | 2021 | 2908 | 1.030 |
Why?
|
| Antihypertensive Agents | 7 | 2023 | 2030 | 0.980 |
Why?
|
| Exercise | 5 | 2023 | 5945 | 0.970 |
Why?
|
| Bayes Theorem | 19 | 2024 | 2353 | 0.970 |
Why?
|
| Epidemiology | 4 | 2017 | 278 | 0.950 |
Why?
|
| Unionidae | 1 | 2024 | 1 | 0.940 |
Why?
|
| Physicians, Family | 2 | 2017 | 348 | 0.930 |
Why?
|
| Registries | 15 | 2021 | 8352 | 0.930 |
Why?
|
| Socioeconomic Factors | 21 | 2023 | 7841 | 0.910 |
Why?
|
| Hepatitis B | 2 | 2020 | 710 | 0.880 |
Why?
|
| Rural Population | 8 | 2023 | 2321 | 0.880 |
Why?
|
| Automobiles | 2 | 2021 | 103 | 0.860 |
Why?
|
| Central Nervous System Neoplasms | 2 | 2022 | 926 | 0.860 |
Why?
|
| Environmental Exposure | 7 | 2024 | 4544 | 0.850 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 5 | 2022 | 3246 | 0.850 |
Why?
|
| Aged | 82 | 2024 | 171344 | 0.840 |
Why?
|
| Tooth, Deciduous | 1 | 2022 | 76 | 0.810 |
Why?
|
| Young Adult | 50 | 2024 | 59939 | 0.790 |
Why?
|
| Middle Aged | 92 | 2024 | 223267 | 0.790 |
Why?
|
| Head Protective Devices | 2 | 2021 | 118 | 0.780 |
Why?
|
| Tooth Loss | 1 | 2023 | 198 | 0.750 |
Why?
|
| Mercury | 1 | 2024 | 289 | 0.740 |
Why?
|
| Income | 9 | 2022 | 1876 | 0.740 |
Why?
|
| Breast Neoplasms, Male | 1 | 2023 | 213 | 0.740 |
Why?
|
| Polypharmacy | 1 | 2024 | 307 | 0.730 |
Why?
|
| Cities | 3 | 2024 | 542 | 0.730 |
Why?
|
| Peptic Ulcer | 1 | 2022 | 214 | 0.720 |
Why?
|
| Rural Health Services | 2 | 2017 | 393 | 0.720 |
Why?
|
| Cause of Death | 13 | 2021 | 3717 | 0.720 |
Why?
|
| Blood Pressure | 13 | 2023 | 8533 | 0.700 |
Why?
|
| Hypertriglyceridemia | 1 | 2023 | 292 | 0.700 |
Why?
|
| Maternal Mortality | 2 | 2021 | 310 | 0.680 |
Why?
|
| Economics | 1 | 2020 | 141 | 0.670 |
Why?
|
| Seat Belts | 1 | 2019 | 60 | 0.660 |
Why?
|
| Metals, Heavy | 1 | 2021 | 149 | 0.650 |
Why?
|
| Bone Diseases, Metabolic | 1 | 2023 | 407 | 0.650 |
Why?
|
| Respiration Disorders | 1 | 2022 | 364 | 0.650 |
Why?
|
| Models, Statistical | 13 | 2021 | 5092 | 0.650 |
Why?
|
| Body Mass Index | 16 | 2022 | 13050 | 0.630 |
Why?
|
| Health Policy | 4 | 2023 | 2697 | 0.610 |
Why?
|
| Adolescent | 45 | 2024 | 88902 | 0.610 |
Why?
|
| Infant, Newborn | 27 | 2024 | 26387 | 0.600 |
Why?
|
| Asthma | 6 | 2022 | 6266 | 0.600 |
Why?
|
| Health Status | 7 | 2024 | 4087 | 0.590 |
Why?
|
| Pesticides | 1 | 2021 | 297 | 0.590 |
Why?
|
| Helicobacter Infections | 2 | 2021 | 390 | 0.590 |
Why?
|
| Insulin Infusion Systems | 1 | 2019 | 221 | 0.590 |
Why?
|
| Bibliometrics | 1 | 2021 | 355 | 0.580 |
Why?
|
| Goals | 3 | 2019 | 717 | 0.570 |
Why?
|
| Helicobacter pylori | 1 | 2021 | 380 | 0.570 |
Why?
|
| Vital Statistics | 1 | 2017 | 31 | 0.550 |
Why?
|
| Transportation | 1 | 2018 | 216 | 0.550 |
Why?
|
| Stroke | 7 | 2022 | 9744 | 0.540 |
Why?
|
| Public Health | 6 | 2021 | 2680 | 0.520 |
Why?
|
| Liver Neoplasms | 3 | 2022 | 4356 | 0.510 |
Why?
|
| Population Surveillance | 4 | 2020 | 2594 | 0.500 |
Why?
|
| Data Collection | 3 | 2022 | 3321 | 0.490 |
Why?
|
| Government Programs | 1 | 2017 | 278 | 0.480 |
Why?
|
| Genital Neoplasms, Female | 1 | 2020 | 534 | 0.480 |
Why?
|
| Environmental Monitoring | 4 | 2024 | 1467 | 0.480 |
Why?
|
| Urologic Neoplasms | 1 | 2018 | 312 | 0.470 |
Why?
|
| Commerce | 1 | 2020 | 614 | 0.470 |
Why?
|
| Heart Valve Diseases | 1 | 2022 | 1029 | 0.460 |
Why?
|
| Midwifery | 1 | 2016 | 131 | 0.460 |
Why?
|
| Guidelines as Topic | 2 | 2021 | 1394 | 0.460 |
Why?
|
| Infant | 25 | 2024 | 36459 | 0.460 |
Why?
|
| Child, Preschool | 27 | 2024 | 42577 | 0.460 |
Why?
|
| Leukemia | 1 | 2022 | 1521 | 0.450 |
Why?
|
| Uterine Cervical Neoplasms | 2 | 2024 | 2039 | 0.450 |
Why?
|
| Life Style | 5 | 2024 | 3926 | 0.450 |
Why?
|
| Disability Evaluation | 3 | 2019 | 1828 | 0.450 |
Why?
|
| Environmental Illness | 1 | 2014 | 33 | 0.450 |
Why?
|
| Safety | 1 | 2018 | 1157 | 0.440 |
Why?
|
| Program Development | 1 | 2020 | 1297 | 0.440 |
Why?
|
| Air Pollution | 4 | 2023 | 2377 | 0.440 |
Why?
|
| Social Class | 6 | 2022 | 2007 | 0.440 |
Why?
|
| Feedback | 3 | 2023 | 797 | 0.430 |
Why?
|
| Earthquakes | 1 | 2016 | 192 | 0.430 |
Why?
|
| DMF Index | 2 | 2023 | 86 | 0.430 |
Why?
|
| Motivation | 1 | 2023 | 2020 | 0.430 |
Why?
|
| Sodium | 1 | 2018 | 1594 | 0.430 |
Why?
|
| Diabetes, Gestational | 4 | 2023 | 1263 | 0.420 |
Why?
|
| Neoplasms | 8 | 2022 | 22350 | 0.420 |
Why?
|
| Aged, 80 and over | 31 | 2024 | 59548 | 0.420 |
Why?
|
| Nutritional Status | 2 | 2021 | 1621 | 0.410 |
Why?
|
| Alcohol Drinking | 3 | 2024 | 4045 | 0.410 |
Why?
|
| Research Design | 5 | 2018 | 6206 | 0.410 |
Why?
|
| Urinary Bladder Neoplasms | 2 | 2022 | 2186 | 0.410 |
Why?
|
| Health Knowledge, Attitudes, Practice | 2 | 2018 | 4056 | 0.410 |
Why?
|
| National Health Programs | 1 | 2016 | 443 | 0.410 |
Why?
|
| Renal Insufficiency, Chronic | 2 | 2024 | 2306 | 0.400 |
Why?
|
| Liver Cirrhosis | 2 | 2022 | 1960 | 0.400 |
Why?
|
| Health Status Disparities | 5 | 2021 | 1880 | 0.400 |
Why?
|
| Multilevel Analysis | 5 | 2014 | 148 | 0.390 |
Why?
|
| Child | 31 | 2024 | 80670 | 0.390 |
Why?
|
| Metabolome | 2 | 2019 | 1008 | 0.390 |
Why?
|
| Diabetes Mellitus, Type 2 | 5 | 2024 | 12246 | 0.390 |
Why?
|
| Awareness | 1 | 2016 | 653 | 0.380 |
Why?
|
| Regression Analysis | 9 | 2021 | 6329 | 0.380 |
Why?
|
| Medical Records | 2 | 2014 | 1408 | 0.370 |
Why?
|
| World Health Organization | 4 | 2023 | 1327 | 0.370 |
Why?
|
| Oral Health | 3 | 2023 | 492 | 0.360 |
Why?
|
| Diabetes Mellitus, Type 1 | 2 | 2023 | 3446 | 0.360 |
Why?
|
| History, 20th Century | 4 | 2020 | 2764 | 0.360 |
Why?
|
| Arsenic | 2 | 2024 | 357 | 0.350 |
Why?
|
| History, 21st Century | 4 | 2020 | 1574 | 0.350 |
Why?
|
| Disasters | 1 | 2016 | 521 | 0.340 |
Why?
|
| Primary Health Care | 5 | 2021 | 4735 | 0.340 |
Why?
|
| Policy Making | 1 | 2014 | 546 | 0.340 |
Why?
|
| Multiple Sclerosis | 2 | 2023 | 3229 | 0.340 |
Why?
|
| Vitamins | 1 | 2018 | 1631 | 0.340 |
Why?
|
| Cesarean Section | 3 | 2023 | 1418 | 0.330 |
Why?
|
| Metals | 2 | 2024 | 711 | 0.330 |
Why?
|
| Osteoporosis | 3 | 2024 | 1581 | 0.330 |
Why?
|
| Cholesterol | 6 | 2022 | 2904 | 0.320 |
Why?
|
| Fraud | 2 | 2020 | 66 | 0.310 |
Why?
|
| Photography | 2 | 2022 | 536 | 0.310 |
Why?
|
| Mental Disorders | 2 | 2022 | 6869 | 0.310 |
Why?
|
| Smoking Cessation | 1 | 2020 | 2085 | 0.300 |
Why?
|
| Smoking | 6 | 2021 | 9077 | 0.300 |
Why?
|
| Sarcopenia | 2 | 2024 | 378 | 0.300 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2021 | 2329 | 0.300 |
Why?
|
| Lead | 2 | 2024 | 882 | 0.300 |
Why?
|
| Amino Acids | 4 | 2023 | 1711 | 0.300 |
Why?
|
| Lung Neoplasms | 3 | 2022 | 13489 | 0.300 |
Why?
|
| Blood Glucose | 9 | 2023 | 6422 | 0.290 |
Why?
|
| Health Services Accessibility | 4 | 2022 | 5513 | 0.290 |
Why?
|
| Kidney | 1 | 2023 | 7073 | 0.280 |
Why?
|
| Vision Disorders | 1 | 2014 | 1090 | 0.280 |
Why?
|
| Lipids | 1 | 2018 | 3322 | 0.280 |
Why?
|
| Kidney Neoplasms | 1 | 2024 | 4282 | 0.280 |
Why?
|
| Ovarian Neoplasms | 1 | 2024 | 4903 | 0.270 |
Why?
|
| Sex Factors | 12 | 2021 | 10619 | 0.270 |
Why?
|
| Databases, Factual | 10 | 2021 | 8065 | 0.270 |
Why?
|
| Aspirin | 4 | 2024 | 3134 | 0.270 |
Why?
|
| Time Factors | 15 | 2021 | 40149 | 0.270 |
Why?
|
| Reference Values | 2 | 2024 | 4914 | 0.270 |
Why?
|
| Risk Assessment | 14 | 2023 | 24299 | 0.260 |
Why?
|
| Dyslipidemias | 1 | 2014 | 872 | 0.260 |
Why?
|
| Markov Chains | 5 | 2020 | 974 | 0.260 |
Why?
|
| Bipolar Disorder | 1 | 2023 | 5130 | 0.260 |
Why?
|
| Health Services Needs and Demand | 1 | 2014 | 1404 | 0.250 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 1 | 2010 | 453 | 0.250 |
Why?
|
| Age Factors | 13 | 2021 | 18397 | 0.240 |
Why?
|
| Hospitals | 2 | 2021 | 3885 | 0.240 |
Why?
|
| Demography | 3 | 2021 | 1641 | 0.240 |
Why?
|
| Computer Simulation | 1 | 2018 | 6258 | 0.240 |
Why?
|
| Insulin | 1 | 2019 | 6608 | 0.240 |
Why?
|
| Vitamin D | 1 | 2018 | 3270 | 0.230 |
Why?
|
| Pyridoxine | 1 | 2024 | 108 | 0.230 |
Why?
|
| Health Promotion | 1 | 2016 | 2209 | 0.230 |
Why?
|
| Pancreatic Neoplasms | 2 | 2021 | 5444 | 0.230 |
Why?
|
| Carnitine | 3 | 2022 | 253 | 0.220 |
Why?
|
| Projection | 1 | 2023 | 18 | 0.220 |
Why?
|
| Prescriptions | 2 | 2024 | 388 | 0.220 |
Why?
|
| Healthcare Disparities | 3 | 2020 | 3411 | 0.220 |
Why?
|
| Dentition, Permanent | 1 | 2023 | 22 | 0.220 |
Why?
|
| Geography | 3 | 2021 | 651 | 0.220 |
Why?
|
| Aluminum | 1 | 2024 | 150 | 0.220 |
Why?
|
| Nickel | 1 | 2024 | 126 | 0.210 |
Why?
|
| Chromium | 1 | 2024 | 133 | 0.210 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 1 | 2024 | 355 | 0.210 |
Why?
|
| Substance-Related Disorders | 2 | 2024 | 4421 | 0.210 |
Why?
|
| Tunisia | 1 | 2022 | 36 | 0.210 |
Why?
|
| Early Detection of Cancer | 3 | 2022 | 3235 | 0.210 |
Why?
|
| Alkaloids | 1 | 2024 | 192 | 0.210 |
Why?
|
| Cadmium | 1 | 2024 | 218 | 0.210 |
Why?
|
| Toothbrushing | 1 | 2022 | 48 | 0.200 |
Why?
|
| Lebanon | 1 | 2023 | 246 | 0.200 |
Why?
|
| Chronic Disease | 2 | 2015 | 9358 | 0.200 |
Why?
|
| Niacinamide | 1 | 2024 | 419 | 0.200 |
Why?
|
| Risk Reduction Behavior | 2 | 2019 | 1120 | 0.200 |
Why?
|
| Fetal Macrosomia | 4 | 2023 | 138 | 0.200 |
Why?
|
| Colorectal Neoplasms | 1 | 2022 | 6965 | 0.200 |
Why?
|
| Clinical Protocols | 4 | 2014 | 1438 | 0.200 |
Why?
|
| Pandemics | 4 | 2022 | 8734 | 0.190 |
Why?
|
| Data Mining | 2 | 2018 | 560 | 0.190 |
Why?
|
| Calcium, Dietary | 1 | 2024 | 527 | 0.190 |
Why?
|
| Disease Outbreaks | 2 | 2014 | 1761 | 0.190 |
Why?
|
| Tobacco, Smokeless | 1 | 2022 | 132 | 0.190 |
Why?
|
| PubMed | 1 | 2021 | 129 | 0.180 |
Why?
|
| Pregnancy Complications | 2 | 2017 | 2971 | 0.180 |
Why?
|
| Rheumatic Heart Disease | 1 | 2022 | 163 | 0.180 |
Why?
|
| Sampling Studies | 1 | 2022 | 614 | 0.180 |
Why?
|
| Insulin Resistance | 3 | 2022 | 3989 | 0.180 |
Why?
|
| Skin Neoplasms | 1 | 2020 | 5860 | 0.180 |
Why?
|
| Premature Birth | 2 | 2023 | 1830 | 0.180 |
Why?
|
| Pregnancy in Diabetics | 1 | 2022 | 198 | 0.180 |
Why?
|
| Metabolomics | 5 | 2023 | 1674 | 0.180 |
Why?
|
| Gallbladder | 1 | 2021 | 308 | 0.170 |
Why?
|
| Child, Hospitalized | 1 | 2021 | 181 | 0.170 |
Why?
|
| Autonomic Nervous System Diseases | 1 | 2023 | 270 | 0.170 |
Why?
|
| Lip | 1 | 2021 | 196 | 0.170 |
Why?
|
| Health Transition | 2 | 2019 | 35 | 0.170 |
Why?
|
| Poverty Areas | 1 | 2021 | 268 | 0.160 |
Why?
|
| Ozone | 1 | 2023 | 497 | 0.160 |
Why?
|
| Urban Population | 3 | 2022 | 2040 | 0.160 |
Why?
|
| Housing | 1 | 2024 | 683 | 0.160 |
Why?
|
| History of Medicine | 1 | 2019 | 42 | 0.160 |
Why?
|
| Sphingomyelins | 1 | 2019 | 104 | 0.160 |
Why?
|
| Systole | 1 | 2021 | 935 | 0.160 |
Why?
|
| Influenza, Human | 1 | 2010 | 1543 | 0.150 |
Why?
|
| Mediterranean Region | 4 | 2019 | 47 | 0.150 |
Why?
|
| Telecommunications | 1 | 2018 | 79 | 0.150 |
Why?
|
| Mitral Valve Prolapse | 1 | 2020 | 213 | 0.150 |
Why?
|
| Thyroid Neoplasms | 2 | 2022 | 2355 | 0.150 |
Why?
|
| Diet | 3 | 2023 | 8088 | 0.150 |
Why?
|
| Fruit | 1 | 2023 | 1166 | 0.150 |
Why?
|
| Insurance, Health | 3 | 2020 | 2520 | 0.150 |
Why?
|
| Hypothyroidism | 1 | 2023 | 665 | 0.150 |
Why?
|
| Taxes | 1 | 2020 | 219 | 0.150 |
Why?
|
| Breast Neoplasms | 2 | 2022 | 21162 | 0.150 |
Why?
|
| Australia | 1 | 2021 | 1263 | 0.150 |
Why?
|
| Policy | 1 | 2021 | 512 | 0.140 |
Why?
|
| Monte Carlo Method | 4 | 2020 | 1251 | 0.140 |
Why?
|
| Phosphatidylcholines | 1 | 2019 | 404 | 0.140 |
Why?
|
| Aging | 4 | 2024 | 8728 | 0.140 |
Why?
|
| Death Certificates | 1 | 2018 | 172 | 0.140 |
Why?
|
| Magnetite Nanoparticles | 1 | 2019 | 310 | 0.140 |
Why?
|
| Anthropometry | 1 | 2022 | 1336 | 0.140 |
Why?
|
| Secondary Prevention | 1 | 2023 | 1469 | 0.140 |
Why?
|
| Japan | 1 | 2021 | 1418 | 0.140 |
Why?
|
| State Health Plans | 1 | 2019 | 220 | 0.140 |
Why?
|
| Health Services | 1 | 2022 | 755 | 0.140 |
Why?
|
| Infant, Newborn, Diseases | 1 | 2022 | 587 | 0.140 |
Why?
|
| Peer Group | 1 | 2022 | 702 | 0.130 |
Why?
|
| Lysophospholipids | 1 | 2019 | 336 | 0.130 |
Why?
|
| Pregnancy | 10 | 2023 | 30236 | 0.130 |
Why?
|
| Primary Prevention | 1 | 2024 | 1188 | 0.130 |
Why?
|
| Visually Impaired Persons | 1 | 2017 | 79 | 0.130 |
Why?
|
| Headache Disorders | 1 | 2019 | 152 | 0.130 |
Why?
|
| Urinalysis | 1 | 2018 | 369 | 0.130 |
Why?
|
| Reference Standards | 1 | 2020 | 1010 | 0.130 |
Why?
|
| Nitrogen Dioxide | 1 | 2019 | 535 | 0.130 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 3 | 2022 | 3250 | 0.130 |
Why?
|
| Blood Pressure Determination | 1 | 2020 | 646 | 0.130 |
Why?
|
| Social Problems | 1 | 2016 | 107 | 0.130 |
Why?
|
| Forecasting | 2 | 2022 | 2936 | 0.130 |
Why?
|
| Censuses | 1 | 2017 | 198 | 0.130 |
Why?
|
| Survival Rate | 3 | 2019 | 12826 | 0.130 |
Why?
|
| Regeneration | 1 | 2024 | 1520 | 0.130 |
Why?
|
| Gastrointestinal Diseases | 2 | 2014 | 1203 | 0.130 |
Why?
|
| Homicide | 1 | 2018 | 294 | 0.130 |
Why?
|
| Aortic Valve Insufficiency | 1 | 2020 | 575 | 0.120 |
Why?
|
| Achievement | 1 | 2017 | 287 | 0.120 |
Why?
|
| Central Nervous System | 1 | 2022 | 1345 | 0.120 |
Why?
|
| Vision, Low | 1 | 2017 | 162 | 0.120 |
Why?
|
| Bronchitis, Chronic | 1 | 2016 | 81 | 0.120 |
Why?
|
| Neck Pain | 1 | 2017 | 190 | 0.120 |
Why?
|
| Developed Countries | 3 | 2023 | 453 | 0.120 |
Why?
|
| Tandem Mass Spectrometry | 4 | 2022 | 1198 | 0.120 |
Why?
|
| Phenols | 1 | 2019 | 526 | 0.120 |
Why?
|
| Diabetes Complications | 1 | 2021 | 1319 | 0.120 |
Why?
|
| Task Performance and Analysis | 1 | 2018 | 771 | 0.120 |
Why?
|
| Self Report | 3 | 2023 | 3771 | 0.120 |
Why?
|
| Family Practice | 1 | 2017 | 508 | 0.120 |
Why?
|
| Fast Foods | 1 | 2016 | 220 | 0.110 |
Why?
|
| Publishing | 1 | 2021 | 837 | 0.110 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 2022 | 2204 | 0.110 |
Why?
|
| Cholesterol, LDL | 1 | 2023 | 2392 | 0.110 |
Why?
|
| Environmental Pollutants | 1 | 2023 | 1292 | 0.110 |
Why?
|
| Gastrointestinal Neoplasms | 2 | 2020 | 957 | 0.110 |
Why?
|
| Food Labeling | 1 | 2016 | 181 | 0.110 |
Why?
|
| Stress, Mechanical | 1 | 2019 | 1674 | 0.110 |
Why?
|
| Opium | 1 | 2013 | 28 | 0.110 |
Why?
|
| Dental Health Services | 1 | 2013 | 48 | 0.110 |
Why?
|
| Pre-Eclampsia | 1 | 2023 | 1256 | 0.110 |
Why?
|
| Normal Distribution | 1 | 2014 | 267 | 0.110 |
Why?
|
| Nutrition Surveys | 1 | 2021 | 1737 | 0.110 |
Why?
|
| Chromatography, Liquid | 3 | 2022 | 996 | 0.110 |
Why?
|
| China | 1 | 2019 | 2386 | 0.110 |
Why?
|
| Blindness | 1 | 2017 | 585 | 0.110 |
Why?
|
| Dementia | 3 | 2019 | 2741 | 0.110 |
Why?
|
| Diarrhea | 2 | 2016 | 1317 | 0.100 |
Why?
|
| Review Literature as Topic | 1 | 2014 | 297 | 0.100 |
Why?
|
| Testicular Neoplasms | 1 | 2019 | 806 | 0.100 |
Why?
|
| Decision Trees | 1 | 2014 | 508 | 0.100 |
Why?
|
| Diuretics | 1 | 2016 | 614 | 0.100 |
Why?
|
| Principal Component Analysis | 1 | 2016 | 949 | 0.100 |
Why?
|
| Bone Density | 2 | 2022 | 3491 | 0.100 |
Why?
|
| Prisons | 1 | 2014 | 178 | 0.100 |
Why?
|
| Muscle, Skeletal | 2 | 2024 | 4968 | 0.100 |
Why?
|
| Calcium Channel Blockers | 1 | 2016 | 687 | 0.100 |
Why?
|
| Urbanization | 1 | 2013 | 100 | 0.100 |
Why?
|
| Wounds, Gunshot | 1 | 2018 | 586 | 0.100 |
Why?
|
| HIV Infections | 5 | 2022 | 17532 | 0.100 |
Why?
|
| Health Behavior | 2 | 2021 | 2649 | 0.100 |
Why?
|
| alpha-Synuclein | 1 | 2019 | 771 | 0.100 |
Why?
|
| Benzhydryl Compounds | 1 | 2019 | 944 | 0.100 |
Why?
|
| Ascorbic Acid | 1 | 2015 | 658 | 0.100 |
Why?
|
| Insurance, Pharmaceutical Services | 1 | 2014 | 347 | 0.100 |
Why?
|
| Survival Analysis | 3 | 2020 | 10101 | 0.100 |
Why?
|
| Pregnancy Outcome | 4 | 2023 | 2971 | 0.100 |
Why?
|
| Respiratory Tract Infections | 1 | 2019 | 1008 | 0.100 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 2 | 2016 | 1514 | 0.100 |
Why?
|
| Mouth Diseases | 1 | 2014 | 239 | 0.090 |
Why?
|
| Prescription Drugs | 1 | 2018 | 634 | 0.090 |
Why?
|
| Narcotics | 1 | 2013 | 332 | 0.090 |
Why?
|
| Calcinosis | 1 | 2020 | 1480 | 0.090 |
Why?
|
| Vitamin E | 1 | 2015 | 872 | 0.090 |
Why?
|
| Logistic Models | 3 | 2022 | 13276 | 0.090 |
Why?
|
| International Classification of Diseases | 1 | 2017 | 935 | 0.090 |
Why?
|
| Health Care Reform | 1 | 2020 | 1256 | 0.090 |
Why?
|
| Firearms | 1 | 2018 | 630 | 0.090 |
Why?
|
| Drug Prescriptions | 1 | 2020 | 1663 | 0.090 |
Why?
|
| Delivery of Health Care | 4 | 2022 | 5367 | 0.090 |
Why?
|
| Equipment Design | 1 | 2018 | 3488 | 0.090 |
Why?
|
| Case-Control Studies | 4 | 2022 | 22248 | 0.090 |
Why?
|
| Mitral Valve Insufficiency | 1 | 2020 | 1414 | 0.090 |
Why?
|
| Prognosis | 3 | 2021 | 29959 | 0.090 |
Why?
|
| Research | 1 | 2018 | 1977 | 0.090 |
Why?
|
| Patient Acceptance of Health Care | 2 | 2022 | 3230 | 0.090 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2016 | 1241 | 0.090 |
Why?
|
| Neurodegenerative Diseases | 1 | 2019 | 1089 | 0.090 |
Why?
|
| Substance Abuse, Intravenous | 1 | 2014 | 530 | 0.080 |
Why?
|
| Aortic Valve | 1 | 2020 | 1966 | 0.080 |
Why?
|
| Respiratory Tract Diseases | 1 | 2015 | 744 | 0.080 |
Why?
|
| Glucose Tolerance Test | 2 | 2023 | 1180 | 0.080 |
Why?
|
| Psychiatry | 1 | 2022 | 1715 | 0.080 |
Why?
|
| Gout | 1 | 2017 | 622 | 0.080 |
Why?
|
| Education, Medical | 1 | 2021 | 1744 | 0.080 |
Why?
|
| Meta-Analysis as Topic | 1 | 2014 | 1365 | 0.080 |
Why?
|
| DNA Damage | 1 | 2019 | 2469 | 0.080 |
Why?
|
| Angiotensin Receptor Antagonists | 1 | 2016 | 1065 | 0.080 |
Why?
|
| Osteoarthritis | 1 | 2017 | 1072 | 0.080 |
Why?
|
| Metabolic Diseases | 1 | 2015 | 686 | 0.080 |
Why?
|
| Comorbidity | 2 | 2023 | 10580 | 0.080 |
Why?
|
| Program Evaluation | 1 | 2017 | 2504 | 0.080 |
Why?
|
| Low Back Pain | 1 | 2017 | 986 | 0.080 |
Why?
|
| Organizational Objectives | 3 | 2014 | 426 | 0.070 |
Why?
|
| Preventive Health Services | 1 | 2013 | 570 | 0.070 |
Why?
|
| Antioxidants | 1 | 2015 | 1671 | 0.070 |
Why?
|
| Aortic Valve Stenosis | 1 | 2020 | 2023 | 0.070 |
Why?
|
| Retrospective Studies | 6 | 2023 | 81657 | 0.070 |
Why?
|
| Suicide | 1 | 2018 | 1606 | 0.070 |
Why?
|
| Occupational Diseases | 1 | 2015 | 1456 | 0.070 |
Why?
|
| Health Resources | 1 | 2013 | 950 | 0.070 |
Why?
|
| International Cooperation | 1 | 2013 | 1434 | 0.070 |
Why?
|
| Communicable Diseases | 1 | 2015 | 872 | 0.070 |
Why?
|
| Nutrition Policy | 1 | 2011 | 467 | 0.070 |
Why?
|
| Precancerous Conditions | 1 | 2013 | 980 | 0.070 |
Why?
|
| Vaccination | 1 | 2019 | 3435 | 0.070 |
Why?
|
| Universities | 2 | 2022 | 1004 | 0.070 |
Why?
|
| Fasting | 3 | 2023 | 1609 | 0.060 |
Why?
|
| Biomedical Research | 1 | 2021 | 3459 | 0.060 |
Why?
|
| Poverty | 3 | 2022 | 2714 | 0.060 |
Why?
|
| DNA | 1 | 2019 | 7210 | 0.060 |
Why?
|
| Liver Diseases | 1 | 2014 | 1303 | 0.060 |
Why?
|
| Morbidity | 2 | 2020 | 1754 | 0.060 |
Why?
|
| Malaria | 1 | 2014 | 1246 | 0.060 |
Why?
|
| Treatment Outcome | 4 | 2019 | 65286 | 0.060 |
Why?
|
| Depressive Disorder, Major | 1 | 2022 | 4810 | 0.060 |
Why?
|
| Risk | 2 | 2013 | 9602 | 0.060 |
Why?
|
| Double-Blind Method | 1 | 2018 | 12430 | 0.060 |
Why?
|
| Reproducibility of Results | 3 | 2021 | 20146 | 0.060 |
Why?
|
| Heroin | 1 | 2024 | 120 | 0.060 |
Why?
|
| Colitis, Ulcerative | 1 | 2016 | 1920 | 0.050 |
Why?
|
| Phenotype | 2 | 2018 | 16722 | 0.050 |
Why?
|
| Crohn Disease | 1 | 2016 | 2286 | 0.050 |
Why?
|
| Fibrinolytic Agents | 1 | 2012 | 2078 | 0.050 |
Why?
|
| Models, Theoretical | 3 | 2021 | 3563 | 0.050 |
Why?
|
| Dietary Supplements | 1 | 2015 | 3429 | 0.050 |
Why?
|
| Methamphetamine | 1 | 2024 | 167 | 0.050 |
Why?
|
| Inpatients | 1 | 2014 | 2566 | 0.050 |
Why?
|
| Kidney Failure, Chronic | 1 | 2014 | 2505 | 0.050 |
Why?
|
| Atrial Fibrillation | 1 | 2021 | 5182 | 0.050 |
Why?
|
| Physicians | 1 | 2020 | 4591 | 0.050 |
Why?
|
| Methadone | 1 | 2024 | 317 | 0.050 |
Why?
|
| Algorithms | 2 | 2020 | 14073 | 0.050 |
Why?
|
| Neglected Diseases | 1 | 2022 | 67 | 0.050 |
Why?
|
| Enalapril | 1 | 2023 | 317 | 0.050 |
Why?
|
| Africa | 2 | 2016 | 725 | 0.050 |
Why?
|
| Diagnostic Techniques and Procedures | 1 | 2023 | 216 | 0.050 |
Why?
|
| Tuberculosis | 1 | 2014 | 2011 | 0.050 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2017 | 3788 | 0.050 |
Why?
|
| Seroepidemiologic Studies | 1 | 2022 | 404 | 0.050 |
Why?
|
| Small-Area Analysis | 1 | 2021 | 51 | 0.050 |
Why?
|
| Animals | 5 | 2024 | 168939 | 0.050 |
Why?
|
| Educational Status | 2 | 2020 | 2510 | 0.050 |
Why?
|
| Severity of Illness Index | 1 | 2019 | 15912 | 0.050 |
Why?
|
| Space-Time Clustering | 1 | 2020 | 45 | 0.040 |
Why?
|
| Amyloid beta-Peptides | 1 | 2014 | 3886 | 0.040 |
Why?
|
| Africa South of the Sahara | 1 | 2022 | 751 | 0.040 |
Why?
|
| NAD | 1 | 2024 | 617 | 0.040 |
Why?
|
| Persia | 1 | 2019 | 7 | 0.040 |
Why?
|
| England | 1 | 2021 | 533 | 0.040 |
Why?
|
| Glycine | 1 | 2023 | 670 | 0.040 |
Why?
|
| Heart Failure | 2 | 2014 | 11879 | 0.040 |
Why?
|
| Linear Models | 2 | 2019 | 5873 | 0.040 |
Why?
|
| Dielectric Spectroscopy | 1 | 2019 | 30 | 0.040 |
Why?
|
| Palladium | 1 | 2019 | 67 | 0.040 |
Why?
|
| Proportional Hazards Models | 3 | 2019 | 12536 | 0.040 |
Why?
|
| History, Ancient | 1 | 2019 | 213 | 0.040 |
Why?
|
| Methylene Blue | 1 | 2019 | 156 | 0.040 |
Why?
|
| Gallbladder Neoplasms | 1 | 2020 | 190 | 0.040 |
Why?
|
| Pregnancy Trimester, First | 1 | 2023 | 917 | 0.040 |
Why?
|
| Electrochemical Techniques | 1 | 2019 | 91 | 0.040 |
Why?
|
| Nanotubes, Carbon | 1 | 2019 | 71 | 0.040 |
Why?
|
| Limit of Detection | 1 | 2019 | 271 | 0.040 |
Why?
|
| Vegetables | 1 | 2023 | 1199 | 0.040 |
Why?
|
| Lysophosphatidylcholines | 1 | 2018 | 77 | 0.040 |
Why?
|
| Sample Size | 1 | 2021 | 844 | 0.040 |
Why?
|
| United States | 2 | 2023 | 72945 | 0.040 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2007 | 2270 | 0.040 |
Why?
|
| Chitosan | 1 | 2019 | 138 | 0.040 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 1 | 2019 | 391 | 0.040 |
Why?
|
| Djibouti | 1 | 2017 | 2 | 0.040 |
Why?
|
| Dimerization | 1 | 2019 | 882 | 0.040 |
Why?
|
| Cardiovascular Agents | 1 | 2023 | 849 | 0.030 |
Why?
|
| Somalia | 1 | 2017 | 78 | 0.030 |
Why?
|
| Depression | 1 | 2016 | 8225 | 0.030 |
Why?
|
| Alzheimer Disease | 2 | 2019 | 8715 | 0.030 |
Why?
|
| Electrodes | 1 | 2019 | 612 | 0.030 |
Why?
|
| Absorptiometry, Photon | 1 | 2022 | 1707 | 0.030 |
Why?
|
| Surface Properties | 1 | 2019 | 1153 | 0.030 |
Why?
|
| Brain | 1 | 2022 | 27158 | 0.030 |
Why?
|
| Models, Biological | 1 | 2012 | 9464 | 0.030 |
Why?
|
| Uncertainty | 1 | 2020 | 765 | 0.030 |
Why?
|
| HIV | 1 | 2022 | 1588 | 0.030 |
Why?
|
| Prospective Studies | 4 | 2024 | 54872 | 0.030 |
Why?
|
| Sanitation | 1 | 2015 | 83 | 0.030 |
Why?
|
| Marital Status | 1 | 2016 | 426 | 0.030 |
Why?
|
| Neoplasm Staging | 2 | 2021 | 11218 | 0.030 |
Why?
|
| Particle Size | 1 | 2019 | 1633 | 0.030 |
Why?
|
| Metal Nanoparticles | 1 | 2019 | 400 | 0.030 |
Why?
|
| Disabled Children | 1 | 2017 | 250 | 0.030 |
Why?
|
| Caenorhabditis elegans | 1 | 2024 | 1474 | 0.030 |
Why?
|
| Cost-Benefit Analysis | 1 | 2007 | 5536 | 0.030 |
Why?
|
| Cluster Analysis | 1 | 2021 | 2721 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 2016 | 39312 | 0.030 |
Why?
|
| Diagnostic Techniques, Cardiovascular | 1 | 2015 | 153 | 0.030 |
Why?
|
| Gastritis, Atrophic | 1 | 2013 | 31 | 0.030 |
Why?
|
| Western World | 1 | 2013 | 26 | 0.030 |
Why?
|
| Social Perception | 1 | 2017 | 435 | 0.030 |
Why?
|
| Disease Susceptibility | 1 | 2020 | 1791 | 0.030 |
Why?
|
| Weight Gain | 1 | 2023 | 2356 | 0.030 |
Why?
|
| Cations | 1 | 2014 | 239 | 0.030 |
Why?
|
| Health Care Surveys | 1 | 2020 | 2425 | 0.030 |
Why?
|
| Tumor Burden | 1 | 2019 | 1902 | 0.030 |
Why?
|
| Biosensing Techniques | 1 | 2019 | 641 | 0.030 |
Why?
|
| Thiazides | 1 | 2012 | 19 | 0.030 |
Why?
|
| Metaplasia | 1 | 2013 | 326 | 0.030 |
Why?
|
| Calibration | 1 | 2015 | 814 | 0.030 |
Why?
|
| Warfarin | 1 | 2021 | 1493 | 0.020 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2022 | 10384 | 0.020 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2024 | 2763 | 0.020 |
Why?
|
| Weight Loss | 1 | 2023 | 2712 | 0.020 |
Why?
|
| Cross-Cultural Comparison | 1 | 2015 | 636 | 0.020 |
Why?
|
| Eye Diseases | 1 | 2017 | 660 | 0.020 |
Why?
|
| Myocardial Infarction | 1 | 2012 | 11514 | 0.020 |
Why?
|
| Rectal Neoplasms | 1 | 2020 | 1183 | 0.020 |
Why?
|
| Australasia | 1 | 2011 | 20 | 0.020 |
Why?
|
| Prisoners | 1 | 2014 | 315 | 0.020 |
Why?
|
| Antiretroviral Therapy, Highly Active | 1 | 2019 | 1900 | 0.020 |
Why?
|
| Musculoskeletal Diseases | 1 | 2017 | 598 | 0.020 |
Why?
|
| Neoplasm Invasiveness | 1 | 2019 | 3610 | 0.020 |
Why?
|
| Cohort Studies | 3 | 2019 | 41706 | 0.020 |
Why?
|
| Esophageal Neoplasms | 1 | 2020 | 1661 | 0.020 |
Why?
|
| Health Status Indicators | 1 | 2015 | 968 | 0.020 |
Why?
|
| Glucose | 1 | 2021 | 4340 | 0.020 |
Why?
|
| Risk-Taking | 1 | 2014 | 1022 | 0.020 |
Why?
|
| Models, Molecular | 1 | 2019 | 5388 | 0.020 |
Why?
|
| Epidemics | 1 | 2014 | 516 | 0.020 |
Why?
|
| Colonic Neoplasms | 1 | 2020 | 2535 | 0.020 |
Why?
|
| Hospitals, General | 1 | 2012 | 804 | 0.020 |
Why?
|
| North America | 1 | 2011 | 1287 | 0.020 |
Why?
|
| Mice | 2 | 2024 | 81898 | 0.020 |
Why?
|
| Cell Differentiation | 1 | 2024 | 11657 | 0.020 |
Why?
|
| Internationality | 1 | 2011 | 1006 | 0.020 |
Why?
|
| Anticoagulants | 1 | 2021 | 4854 | 0.020 |
Why?
|
| Occupational Exposure | 1 | 2015 | 1807 | 0.020 |
Why?
|
| Parkinson Disease | 1 | 2019 | 2884 | 0.020 |
Why?
|
| Data Interpretation, Statistical | 1 | 2014 | 2694 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2021 | 15425 | 0.010 |
Why?
|
| Europe | 1 | 2011 | 3430 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2016 | 12064 | 0.010 |
Why?
|
| Homeostasis | 1 | 2014 | 3343 | 0.010 |
Why?
|
| Quality Indicators, Health Care | 1 | 2012 | 1804 | 0.010 |
Why?
|
| Drug Therapy, Combination | 1 | 2012 | 6306 | 0.010 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 2014 | 2183 | 0.010 |
Why?
|
| Coronary Disease | 1 | 2015 | 5915 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2012 | 8728 | 0.010 |
Why?
|
| Length of Stay | 1 | 2012 | 6491 | 0.010 |
Why?
|
| Quality of Life | 1 | 2020 | 13476 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 2014 | 8045 | 0.010 |
Why?
|